Literature DB >> 21383656

A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.

Denise H Fleming1, Binu S Mathew, Samuel Prasanna, Vellaichamy M Annapandian, George T John.   

Abstract

Enteric-coated mycophenolate sodium (EC-MPS) is widely used in renal transplantation. With a delayed absorption profile, it has not been possible to develop limited sampling strategies to estimate area under the curve (mycophenolic acid [MPA] AUC₀₋₁₂), which have limited time points and are completed in 2 hours. We developed and validated simplified strategies to estimate MPA AUC₀₋₁₂ in an Indian renal transplant population prescribed EC-MPS together with prednisolone and tacrolimus. Intensive pharmacokinetic sampling (17 samples each) was performed in 18 patients to measure MPA AUC₀₋₁₂. The profiles at 1 month were used to develop the simplified strategies and those at 5.5 months used for validation. We followed two approaches. In one, the AUC was calculated using the trapezoidal rule with fewer time points followed by an extrapolation. In the second approach, by stepwise multiple regression analysis, models with different time points were identified and linear regression analysis performed. Using the trapezoidal rule, two equations were developed with six time points and sampling to 6 or 8 hours (8hrAUC[₀₋₁₂exp]) after the EC-MPS dose. On validation, the 8hrAUC(₀₋₁₂exp) compared with total measured AUC₀₋₁₂ had a coefficient of correlation (r²) of 0.872 with a bias and precision (95% confidence interval) of 0.54% (-6.07-7.15) and 9.73% (5.37-14.09), respectively. Second, limited sampling strategies were developed with four, five, six, seven, and eight time points and completion within 2 hours, 4 hours, 6 hours, and 8 hours after the EC-MPS dose. On validation, six, seven, and eight time point equations, all with sampling to 8 hours, had an acceptable r with the total measured MPA AUC₀₋₁₂ (0.817-0.927). In the six, seven, and eight time points, the bias (95% confidence interval) was 3.00% (-4.59 to 10.59), 0.29% (-5.4 to 5.97), and -0.72% (-5.34 to 3.89) and the precision (95% confidence interval) was 10.59% (5.06-16.13), 8.33% (4.55-12.1), and 6.92% (3.94-9.90), respectively. Of the eight simplified approaches, inclusion of seven or eight time points improved the accuracy of the predicted AUC compared with the actual and can be advocated based on the priority of the user.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21383656     DOI: 10.1097/FTD.0b013e31820c16f8

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  5 in total

Review 1.  Maximum a posteriori Bayesian estimation of mycophenolic Acid area under the concentration-time curve: is this clinically useful for dosage prediction yet?

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2011-12-01       Impact factor: 6.447

Review 2.  How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?

Authors:  Azrin N Abd Rahman; Susan E Tett; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2014-03       Impact factor: 6.447

3.  Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure.

Authors:  Jean-Michel Hougardy; Laurette Maufort; Frédéric Cotton; Julien Coussement; Dimitri Mikhalski; Karl M Wissing; Alain Le Moine; Nilufer Broeders; Daniel Abramowicz
Journal:  Clin Kidney J       Date:  2016-03-01

4.  Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation.

Authors:  Joanna Sobiak; Matylda Resztak; Maciej Głyda; Paulina Szczepaniak; Maria Chrzanowska
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-07       Impact factor: 2.441

5.  Estimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium.

Authors:  Yichen Jia; Bo Peng; Long Li; Jina Wang; Xuanchuan Wang; Guisheng Qi; Ruiming Rong; Liming Wang; Jianxin Qiu; Ming Xu; Tongyu Zhu
Journal:  Ther Drug Monit       Date:  2017-02       Impact factor: 3.681

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.